{"id":"NCT00191100","sponsor":"Eli Lilly and Company","briefTitle":"Comparative Study of Gemcitabine,Cisplatin and Radiation Versus Cisplatin and Radiation in Cancer of the Cervix","officialTitle":"Phase 3 Randomized Comparison of Concurrent Gemcitabine, Cisplatin, and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Cancer of the Cervix Stages IIB to IVA","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2002-05","primaryCompletion":"2008-04","completion":"2008-04","firstPosted":"2005-09-19","resultsPosted":"2009-05-25","lastUpdate":"2009-08-11"},"enrollment":515,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Cancer of Cervix"],"interventions":[{"type":"DRUG","name":"Gemcitabine","otherNames":["LY188011","Gemzar"]},{"type":"DRUG","name":"Cisplatin","otherNames":[]},{"type":"RADIATION","name":"Brachytherapy","otherNames":[]},{"type":"RADIATION","name":"Pelvic radiation","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the effectiveness of two methods of treating cancer of the cervix. Half the patients will receive gemcitabine plus cisplatin while undergoing radiation therapy, followed by adjuvant gemcitabine and cisplatin and the other half will receive cisplatin along with radiation therapy without adjuvant therapy.","primaryOutcome":{"measure":"Number of Participants With Progressive Disease or Death Due to Any Cause at 3 Years","timeFrame":"Tumor assessments at baseline, weekly during chemoradiation & brachytherapy, on Day 1 of adjuvant Cycles 1&2 for Arm A, at the 30-day post-study visit, every 4/6 months for 12/48 months of the short/long post-study follow-up periods respectively","effectByArm":[{"arm":"Gemcitabine/Cisplatin/Radiation","deltaMin":55,"sd":null},{"arm":"Cisplatin/Radiation","deltaMin":83,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.029"}]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":5},"locations":{"siteCount":7,"countries":["Argentina","Bosnia and Herzegovina","India","Mexico","Pakistan","Peru","Thailand"]},"refs":{"pmids":["21444871"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":44},"commonTop":["Nausea","Vaginal haemorrhage","Anaemia","Diarrhoea","Neutropenia"]}}